Drug Profile
ZYPH 0907
Alternative Names: ZYPH0907Latest Information Update: 16 Jul 2016
Price :
$50
*
At a glance
- Originator Zydus Cadila
- Class
- Mechanism of Action Parathyroid hormone receptor agonists
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- No development reported Osteoporosis
Most Recent Events
- 16 Jul 2016 No recent reports of development identified for phase-I development in Osteoporosis(In volunteers) in India (PO)
- 15 Apr 2012 Phase-I clinical trials (in volunteers) in Osteoporosis in India (PO)